URGENT MEDICAL DEVICE CORRECTION
Voluntary Labeling Correction for all TRUE METRIX® brand of Blood Glucose Monitoring Systems

The Products may continue to be used and sold.
Trividia is updating the description for the E-5 Error Code in the “Messages” section of the Owner’s Booklets (i.e., Instructions for Use), to highlight that users must contact their healthcare professional immediately if they receive an E-5 error message and are having diabetic symptoms. In such circumstances, as currently written, the E-5 error code description may potentially lead to a delay in treatment. In rare instances, a delay in treatment may result in serious adverse health consequences or death, especially for users with very high blood glucose (higher than 600 mg/dL).
UPDATED INSTRUCTIONS:
| Display | Reason | Action |
|---|---|---|
![]() |
Very high blood glucose results (higher than 600 mg/dL), or Test Strip Error |
WARNING!!! If you are not experiencing symptoms, retest with a new test strip. If the error persists call |
You may continue to use the TRUE METRIX® Products. Products are not to be returned or replaced.
If you have any questions, please call Trividia Health Customer Care Department toll-free at 1-888-835-2723 Monday-Friday 8AM-8PM EST (excluding holidays)
The correction affects all Products sold in the United States, UK, Mexico and the Caribbean, including co-branded products sold under store or distribution partner names:
| Co-Branded Product Names |
|---|
| Care One (Ahold) |
| CenterWell (Humana) |
| CVS |
| Discount Drug Mart |
| Foster & Thrive/Sunmark/Healthmart (McKesson) |
| Good Neighbor Pharmacy (Cencora) |
| HEB |
| Henry Schein |
| HyVee |
| Leader (Cardinal Health) |
| McKesson (Med Surg) |
| Meijer |
| ProCure (WynnMed) |
| Publix |
| Relion (Walmart) |
| Rite Aid |
| Signature Care (Albertsons) |
| Top Care (TopCo) |
| Walgreens |
| Farmacias Benavides (in Mexico) |
| Farmacias Del Ahorro (in Mexico) |
WHAT YOU SHOULD DO:
This correction is being conducted in coordination with the U.S. Food and Drug Administration (“FDA”).
If you would like to view additional information, please click here for the PRESS RELEASE and the PRODUCT NOTICE.
Patient safety is our top priority, and we apologize for any inconvenience this correction may cause you.
